4th Scientific Drug Delivery Conference
REVIEW of our Virtual Conference on FORMULATION DEVELOPMENT and TECHNOLOGIESWe would like to express our deepest thanks to all participants of our virtual 4th Scientific Drug Delivery Conference last Tuesday, 15th February 2022. Hopefully we will see you again in 2024 at our 5th DDC.
Review of our 4th Scientific Drug Delivery Conference
Attendees from over 20 countries joined our virtual Scientific Drug Delivery Conference 2022 on Tuesday 15th February to learn about topics specifically related to drug delivery, about nanotechnology and 3D printing.
We would like to express our heartfelt thanks to each of the participants who gave their time to attend and to contribute.
Losan DDC 2022 Backstage
Due to Covid-19 Pandemic, we had to run our 4th Losan Drug Delivery Conference virtually, which helped us reach new audiences who would not otherwise have attended.
OUR SPEAKERS
A big thank you goes to all the speakers who presented in presence or virtually:
Dr. François Boutignon, Prof. Dr. Werner Weitschies, Dr. Ansgar Bögershausen, Dr. Matthias Rischer, Dr. Karsten Mäder, Dr. Kerstin Schäfer, Prof. Dr. Jörg Breitkreutz, Dr. Simon Geissler, Dr. Wolfgang Mohr and Dr. Philipp Schwarzer .
Many thanks to François Boutignon for the excellent moderation, his overview and his commitment, which contributed to the fact that sometimes we completely forgot that it was not an event in presence.
PRESENTATIONS
DDC 2022 virtual conference
Tuesday, 15th of February 2022
9:00
Welcome & introduction
Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH
Dr. François Boutignon, President & CEO APTYS Pharma
9:20
„Current developments in oral drug delivery systems“
Prof. Dr. Werner Weitschies
Institute of Pharmacy, University of Greifswald
10:00
„Nanoliposome (NLS) technology – a new innovative approach“
Dr. Ansgar Bögershausen and Dr. Matthias Rischer
Losan Pharma GmbH
11:00
„Formulations with phospholipids for the oral application”
Prof. Dr. Karsten Mäder
Institute of Pharmacy, University of Halle
11:40
„Non-conventional formulation development at Boehringer – Ingelheim“
Dr. Kerstin Schäfer
Boehringer-Ingelheim Pharma GmbH & Co. KG
01:30
„Printing technologies for individualized medicines“
Prof. Dr. Jörg Breitkreutz
Institute for Pharmaceutical Technology and Biopharmacy, University of Düsseldorf
02:10
„3D printing“
Dr. Simon Geissler
Merck Healthcare KGaA
03:10
„3D printing – the Losan approach“
Dr. Wolfgang Mohr / Dr. Philipp Schwarzer
Losan Pharma GmbH
03:50
„NanoSolution® case study: using nano milling to improve dissolution rate of abiraterone“
Dr. François Boutignon
President & CEO APTYS Pharma
04:30
Summary and farewell
Dr. Jens Morgenthaler, General Manager
Losan Pharma GmbH
Overview Losan DDC 2022
Date
February 15th, 2022
9:00 – 04:45
Participation fee
free
Virtual conference
Live Streaming with live chat
Symposium language
English
Chairman
Dr. François Boutignon, President & CEO APTYS Pharma
Co Chairman
Dr. Matthias Rischer, Losan Pharma GmbH
